| 糖尿病治疗中多肽类药物新型缓控释给药制剂的研究进展 |
| 投稿时间：2011-05-22 修订日期：2011-12-15 点此下载全文 |
| 引用本文：宣吉明,程玉松,高静,钟延强.糖尿病治疗中多肽类药物新型缓控释给药制剂的研究进展[J].药学实践杂志,2012,30(1):14~18,37 |
| 摘要点击次数: 1944 |
| 全文下载次数: 387 |
|
|
| 中文摘要:多肽类降血糖药物具有模拟正常人的生理性胰岛素分泌的功能,并且其降糖作用与患者血糖水平有关,很少发生低血糖事件。现就治疗糖尿病的多肽类药物新型缓控释制剂作一综述。 |
| 中文关键词:糖尿病治疗 多肽 缓控释给药 |
| |
| Developments of sustained and controlled release delivery systems of peptides in treatment of diabetes |
|
|
| Abstract:Peptide analog of hypoglycemic drugs had a normal physiological function of insulin secretion. The hypoglycemic effect of peptide depended on blood glucose levels of patients, which induced very few incidents of hypoglycemia. Peptides of sustained and controlled release delivery systems in diabetes treatment were summed up in this paper. |
| keywords:diabetes treatment peptide sustained and controlled release delivery systems |
| 查看全文 查看/发表评论 下载PDF阅读器 |
|
| 关闭 |
